Hitoshi Ojima

4.0k citations
102 papers · 2.5k · 1 hit paper · h-index 23

Impact in

  • Oncology top 2%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Gastric Cancer Management and Outcomes
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Esophageal Cancer Research and Treatment 23
    • Esophageal and GI Pathology 9
    • Colorectal Cancer Treatments and Studies 24
    • Colorectal Cancer Surgical Treatments 11
    • Cancer Treatment and Pharmacology 10

Hitoshi Ojima

89 papers receiving 2.5k citations

Hitoshi Ojima's Hit Papers

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01) 2016 · 742 citations
7420+3+6Years since publication200400600

Peers

Hitoshi Ojima
Comparison fields: 5 of 99
  • Oncology 1.3k
  • Pulmonary and Respiratory Medicine 1.3k
  • Gastroenterology 198
  • Surgery 1.4k
  • Cancer Research 340
Replace Marc E. Delclos with:
Marc E. Delclos United States
Hideo Baba Japan
Akira Fukutomi Japan
Suee Lee South Korea
Federica Bertolini Italy
Frank Willeke Germany
Radka Obermannová Czechia
Yoshikazu Uenosono Japan
A. H. Hölscher Germany
Osamu Kainuma Japan
Hitoshi Ojima relative to Marc E. Delclos United States Marc E. Delclos's profile →
Citations per field
00.5×1.5×2.2×
Marc E. Delclos · 1×
Citations per year

Countries citing papers authored by Hitoshi Ojima

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Ojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Ojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Ojima more than expected).

Fields of papers citing papers by Hitoshi Ojima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Ojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Ojima. The network helps show where Hitoshi Ojima may publish in the future.

Co-authors

The 25 scholars most cited alongside Hitoshi Ojima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hitoshi Ojima Line = papers co-authored together Hitoshi Ojima links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
Hit paper breakdown →
2016742
2 2002225
3 2004164
4 2021115
5 200276
6
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
200365
7 200360
8 200355
9 202151
10 200647
11
Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
200346
12 200737
13 201937
14
Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.
200637
15 199735
16
Classification of recurrent esophageal cancer after radical esophagectomy with two- or three-field lymphadenectomy.
200535
17
Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer.
200832
18
Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
200530
19 201429
20 200728

About Hitoshi Ojima

Hitoshi Ojima is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Gastroenterology and Radiology, Nuclear Medicine and Imaging, having authored 102 papers that have together received 2.5k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (28 papers), Colorectal Cancer Treatments and Studies (24 papers), Esophageal Cancer Research and Treatment (23 papers), Gastrointestinal Tumor Research and Treatment (11 papers), Colorectal Cancer Surgical Treatments (11 papers), Cancer Treatment and Pharmacology (10 papers), Esophageal and GI Pathology (9 papers) and Metastasis and carcinoma case studies (9 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.3k citations), Gastroenterology (198 citations), Surgery (1.4k citations) and Cancer Research (340 citations). Hitoshi Ojima has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Hiroyuki Kuwano, Katsuhiko Tsukada, Tatsuya Miyazaki, Masanobu Nakajima, Yasuyuki Fukai, Minoru Fukuchi, Norihiro Masuda, Noboru Oriuchi, Ryokuhei Manda and Makoto Sohda. Their work appears in journals such as Journal of Clinical Oncology, Surgery Today, Cancer, The American Journal of Surgery and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact